The goal of our Right-Track Wrong-Track Analysis is to provide engineers with exceptionally cost-efficient advice early-on in the development process, before tens or hundreds of thousands of dollars are wasted on mistakes a few words from our experts could have prevented.
Nitinol is an amazingly versatile, but exceptionally complicated and metallurgically unique material. As a result, design flaws in Nitinol based products are commonplace. NDC literally employs the people who wrote the books, codes, and standards on its manufacture and use. As an add-on to our Prototype Development services, NDC will run your device design past our team of recognized experts for their gut reactions to your product. We will then provide you with their comments in bullet point format, and call you to discuss the strategic implications.
| NDC’s Right-Track Wrong-Track Analysis includes: Product Design, Material Selection and Specifications, Testing and US Regulatory Submission Considerations, and Manufacturability. Team members include: Craig Bonsignore, Director, Medical Device Design Matt Boyle, Principal Manufacturing Engineer Tom Duerig, President and CEO Bill Ng, Principal Engineer Alan Pelton, Chief Technology Officer Dieter Stöckel, Co-Founder and Director Christine Trépanier, Engineering Fellow Click here to read team member biographies. Each project is reviewed by at least four team members. |
Examples of the type of feedback NDC provides with this service:
|
Whether we redirect you down a more efficient manufacturing track, point you toward a more effective product design, or reassure you that the experts think your prototype is looking good, NDC’s Right-Track Wrong-Track Analysis represents tremendous value at $4,900. Click here to order this service.